Cargando…

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a common malignancy worldwide. The HCC generally develops in the liver of patients already suffering from chronic liver disease. There have been significant advances in both the curative and palliative treatment of HCC. Although liver resection is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuzaki, Ryota, Kanda, Tatsuo, Sasaki, Reina, Matsumoto, Naoki, Nirei, Kazushige, Ogawa, Masahiro, Karp, Seth J., Moriyama, Mitsuhiko, Kogure, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139988/ https://www.ncbi.nlm.nih.gov/pubmed/35626153 http://dx.doi.org/10.3390/cancers14102549

Ejemplares similares

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
por: Masuzaki, Ryota, et al.
Publicado: (2020)

Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy
por: Kanda, Tatsuo, et al.
Publicado: (2023)

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients
por: Nirei, Kazushige, et al.
Publicado: (2021)

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020)

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan
por: Yamana, Yoichiro, et al.
Publicado: (2021)

Knockdown of Mitogen-Activated Protein Kinase Kinase 3 Negatively Regulates Hepatitis A Virus Replication
por: Kanda, Tatsuo, et al.
Publicado: (2021)

Involvement of proliferation of atypical hepatocytes and CDT 1 in the liver cancer of rats administered the diethylnitrosamine
por: Ogawa, Masahiro, et al.
Publicado: (2023)

Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis
por: Kanezawa, Shini, et al.
Publicado: (2023)

Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer
por: Asatani, Shinya, et al.
Publicado: (2021)

Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan
por: Kanda, Tatsuo, et al.
Publicado: (2023)

Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2018)

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease
por: Ogawa, Masahiro, et al.
Publicado: (2019)

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare
por: Kanda, Tatsuo, et al.
Publicado: (2023)

Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan
por: Honda, Masayuki, et al.
Publicado: (2021)

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir
por: Totsuka, Mai, et al.
Publicado: (2021)

Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients
por: Mizutani, Taku, et al.
Publicado: (2022)

Masitinib Inhibits Hepatitis A Virus Replication
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2023)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
por: Sasaki, Reina, et al.
Publicado: (2019)

Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils
por: Matsuoka, Shunichi, et al.
Publicado: (2018)

Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Apoptosis and non-alcoholic fatty liver diseases
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients
por: Nirei, Kazushige, et al.
Publicado: (2017)

The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma
por: Moriyama, Mitsuhiko, et al.
Publicado: (2022)

Rapid Recovery from Acute Liver Failure Secondary to Pancreatoduodenectomy-Related Non-Alcoholic Steatohepatitis
por: Nirei, Kazushige, et al.
Publicado: (2013)

Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus
por: Win, Nan Nwe, et al.
Publicado: (2019)

Expression of Intercellular Adhesion Molecule-1 in the Livers of Rats Treated with Diethylnitrosamine
por: Matsuoka, Shunichi, et al.
Publicado: (2009)

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
por: Watanabe, Yukinobu, et al.
Publicado: (2021)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2017)

Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis
por: Matsuoka, Shunichi, et al.
Publicado: (2009)

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
por: Kanda, Tatsuo, et al.
Publicado: (2019)

Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C
por: Matsumura, Hiroshi, et al.
Publicado: (2012)

Comparison of Local Recurrence in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma with Or Without Accumulation of Iodized Oil Beyond Corona Enhancement Area: Short-term Results
por: Watanabe, Yukinobu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h5q91phm4088abhj1n2am74lbs